Welcome to LookChem.com Sign In|Join Free
  • or
PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID is a heterocyclic compound that features a pyrazolo[1,5-a]pyrimidine core structure with a carboxylic acid functional group. It is a versatile chemical intermediate with applications in various industries, including pharmaceuticals, agrochemicals, and dyestuffs.

25940-35-6

Post Buying Request

25940-35-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

25940-35-6 Usage

Uses

Used in Pharmaceutical Industry:
PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID is used as a pharmaceutical intermediate for the synthesis of various drug molecules. Its unique structure allows it to be a key component in the development of new medications with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical field, PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID serves as an important raw material and intermediate in the production of pesticides and other agrochemical products. Its incorporation into these products can enhance their effectiveness in protecting crops and managing pests.
Used in Dye Stuff Industry:
PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID is also utilized as a reagent and intermediate in the dyestuff industry. Its chemical properties make it suitable for the synthesis of various dyes and pigments, contributing to the development of new colorants for different applications.

Check Digit Verification of cas no

The CAS Registry Mumber 25940-35-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,9,4 and 0 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 25940-35:
(7*2)+(6*5)+(5*9)+(4*4)+(3*0)+(2*3)+(1*5)=116
116 % 10 = 6
So 25940-35-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H5N3O2/c11-7(12)5-4-9-10-3-1-2-8-6(5)10/h1-4H,(H,11,12)

25940-35-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H50318)  Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid, 97%   

  • 25940-35-6

  • 250mg

  • 926.0CNY

  • Detail
  • Alfa Aesar

  • (H50318)  Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid, 97%   

  • 25940-35-6

  • 1g

  • 3334.0CNY

  • Detail
  • Aldrich

  • (739812)  Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid  95%

  • 25940-35-6

  • 739812-1G

  • 1,207.44CNY

  • Detail

25940-35-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID

1.2 Other means of identification

Product number -
Other names Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:25940-35-6 SDS

25940-35-6Downstream Products

25940-35-6Relevant academic research and scientific papers

Efficient, Protecting Group Free Kilogram-Scale Synthesis of the JAK1 Inhibitor GDC-4379

Angelaud, Remy,Burkhard, Johannes,Gosselin, Francis,Lao, David,Marx, Andreas,Ochsenbein, Miriam,Ranjan, Rohit,Stumpf, Andreas,Xu, Di

, p. 2537 - 2550 (2021/11/24)

The development of an improved kilogram-scale synthesis of the JAK1 inhibitorGDC-4379for the treatment of asthma is described. The new process is highlighted by a step-economical construction of a 3-substituted-4-aminopyrazole employing a telescoped oximation and hydrazine condensation of a 1,3-dielectrophile to generate nitrosopyrazole and a novel copper-catalyzed NaBH4reduction of the nitroso group. The endgame process features an amidation of aminopyrazole with acid chloride under Schotten-Baumann conditions to provide access to the penultimate intermediate. A selective N-1 alkylation of the pyrazole moiety was accomplished under phase-transfer conditions, which deliveredGDC-4379with a defined particle-size distribution suitable for micronization after recrystallization and wet milling.

Compound containing 2,4 - thiazole ring and preparation method and application thereof

-

Paragraph 0134; 0135; 0137, (2021/08/25)

The invention provides a compound containing 2,4 - thiazole rings and a preparation method and application thereof, wherein the compound is shown in a formula X. A Is pyrazolopyrimidine or indole. Z Is carbonless. X Is O or S. Y Is - O - or - NH . R1 Hydrogen or C1 -6 Alkyl. R2 Be selected from C1 - C3 Alkyl. C5 - C15 Alkenyl, alkynyl, 5 - RMB 10 heterocyclic radicals, C6 - C12 Aryl, 5 -12 membered heteroaryl, sterol and 5-10 元 cycloalkyl. Y And R2 Connection, or Y and R2 Looping. R3 From hydrogen. Halogen, amino, hydroxyl, acetyl, 3 - RMB 10 heterocyclic group, C6 - C12 Aryl, 5 -12-membered heteroaryl, 3 -10-membered cycloalkyl, ester, carboxy, trihalomethyl and adamantyl. R2 Or R3 It is unsubstituted or is selected from C. 1 - C6 Alkyl. A hydroxy group, a halogen group, a trihalomethyl group, a carboxyl group, and a phenyl group. R2 Document C1 - C3 Alkyl, R3 Hydrogen.

Substituted heteroaryl compounds and compositions and uses thereof

-

Paragraph 0770-0771; 0776-0777, (2017/12/02)

The invention discloses a substituted ceteroary compound as well as a composition and an application thereof. The compound is a compound shown in a formula (I) or a stereisomer, a tautomer, a nitric oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or prodrug of the compound shown in the formula (I). The invention further discloses a pharmaceutical composition including the compound. The compound and the pharmaceutical composition are capable of adjusting the activity of the AK kinase and can be used for preventing, processing, treating and relieving the JAK-mediated disease or disorder.

Pyridines IRAK4 inhibitors, preparation method and application thereof (by machine translation)

-

Paragraph 0092; 0093, (2017/09/01)

The invention belongs to the field of medicine, in particular to a formula (I) of the structural features of pyridine of compound or its pharmaceutically acceptable salt, preparation method thereof, and their use as IRAK4 inhibitors. Experimental results show that, the compound of the invention IRAK4 has prominent inhibit function, can be used for the treatment of autoimmune disease, inflammatory disease, cancer, autoimmune disease and thromboembolism as heterogeneous. (by machine translation)

SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE

-

Paragraph 390, (2015/06/03)

The present invention provides novel heterocyclic compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, treating or lessening the severity of a JAK-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of JAK-mediated disease.

PYRAZOLE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS

-

Page/Page column 89, (2010/04/27)

The present invention relates to a method for controlling invertebrate pests which method comprises treating the pests, their food supply, their habitat or their breeding ground or a plant, seed, soil, area, material or environment in which the pests are growing or may grow, or the materials, plants, seeds, soils, surfaces or spaces to be protected from pest attack or infestation with a pesticidally effective amount of a pyrazole compound of formulae I or II or a salt or an N-oxide thereof, wherein A is a pyrazole radical of the formulae A1 or A2, wherein # denotes the binding; D is a 5- or 6-membered heterocyclic radical fused to the pyrazole moiety; Rp1, Rp2 and Rpx are H, halogen, CN, NO2, C1-C10-alkyl, C2-C10- alkenyl, C2-C10-alkynyl, etc.; n is 0 to 4; or two radicals Rpx bound to the same ring- member may form an oxo substituent, or two radicals Rpx bound to adjacent ring- members may form a 3- to 7-membered fused cyclic radical; B is N or CR4, wherein R4 is H, halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, etc.; X1 is S, O or NR1a, wherein R1a is H, C1-C10-alkyl, etc.; X2 is O2a, NR2bR2c or S(O)mR2d, wherein m is 0, 1 or 2; R2a is C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl, etc.; R2b, R2c are H, C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl, etc.; R2d is C1-C4-alkyl, C1-C4-haloalkyl, C3-C6-cycloalkyl, etc.; R1 is H, CN, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, etc.; R2, R3 and R5 are H, halogen, CN, NO2, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, etc.; to a method for protecting plant propagation material and/or the plants which grow therefrom, to plant propagation material comprising at least one compound of formulae I or II, to a method for treating or protecting an animal from infestation or infection by parasites, to novel pyrazole compounds of formulae I or Il and agricultural composition containing those compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 25940-35-6